Ignite Creation Date:
2024-05-06 @ 3:49 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02388139
Status:
UNKNOWN
Last Update Posted:
2016-01-13
First Post:
2015-03-09
Brief Title:
Cardiovascular Renal and Metabolic Profile in Patients With Acute Myocardial Infarction REN-ACS
Sponsor:
Grigore T Popa University of Medicine and Pharmacy
Organization:
Grigore T Popa University of Medicine and Pharmacy
Study Overview
Official Title:
Cardiovascular Renal and Metabolic Profile in Patients With Acute Myocardial Infarction AMI Included in the Romanian National Programme of Primary Percutaneous Revascularisation - a Single Center Observational Study
Status:
UNKNOWN
Status Verified Date:
2016-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REN-ACS
Brief Summary:
Aims
assessment of renal artery stenosis incidence in consecutive AMI patients included in the Romanian National Programme of Primary Percutaneous Revascularisation
generating a cardio-renal-metabolic profile in patients with renal atherosclerotic disease
creating a local registry based on European CARDS percutaneous interventional registries which also includes renal metabolic and vascular data
reporting long-term follow-up data on major cardiac adverse events MACE in the study group
assessment of renal artery stenosis incidence in consecutive AMI patients included in the Romanian National Programme of Primary Percutaneous Revascularisation
generating a cardio-renal-metabolic profile in patients with renal atherosclerotic disease
creating a local registry based on European CARDS percutaneous interventional registries which also includes renal metabolic and vascular data
reporting long-term follow-up data on major cardiac adverse events MACE in the study group
Detailed Description:
Gathered data
descriptive general demographic data
previous pathologies ischemic heart disease peripheral arterial disease stroke heart failure previous percutaneous coronary interventions coronary artery bypass grafting - CABG known renal disease cardiovascular risk factors age weight height abdominal perimeter body mass index smoking sedentariness diabetes hypertension dyslipidaemia
routine biological data and specific non-genetic biomarkers
information regarding primary PCI less than 12 hours of ischemic symptoms coronarographic details type of used stent periprocedural specific complications final TIMI - thrombolysis in myocardial infarction - flow
echocardiography at admission LVEF
metabolic data obtained from body composition monitoring - body water body fat tissue
renal arteries angiographic details two independent operators evaluate stenosis based on a predefined scale
renal dimensions
measurement of arterial stiffness through Sphigmocore pulsed-wave-velocity 24 hrs post-procedural 2 velocities carotid - femoral and carotid - radial
heart rate variability
in-hospital and one month follow-up MACE
descriptive general demographic data
previous pathologies ischemic heart disease peripheral arterial disease stroke heart failure previous percutaneous coronary interventions coronary artery bypass grafting - CABG known renal disease cardiovascular risk factors age weight height abdominal perimeter body mass index smoking sedentariness diabetes hypertension dyslipidaemia
routine biological data and specific non-genetic biomarkers
information regarding primary PCI less than 12 hours of ischemic symptoms coronarographic details type of used stent periprocedural specific complications final TIMI - thrombolysis in myocardial infarction - flow
echocardiography at admission LVEF
metabolic data obtained from body composition monitoring - body water body fat tissue
renal arteries angiographic details two independent operators evaluate stenosis based on a predefined scale
renal dimensions
measurement of arterial stiffness through Sphigmocore pulsed-wave-velocity 24 hrs post-procedural 2 velocities carotid - femoral and carotid - radial
heart rate variability
in-hospital and one month follow-up MACE
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None